glp 1 drugs and blindness SURGE IN GLP-1 LIKE OZEMPIC SPARKS THOUSANDS OF LAWSUITS OVER ALLEGED SIDE EFFECTS The medications, initially for type 2 diabetes, have driven widespread off-label weight-loss use amid reported gastrointestinal injuries GLP-1 medications and eye problem
Description
13 When both BD and MDD were present, BD superseded
Last month, Lilly announced that orforglipron, an orally available GLP-1 treatment, significantly lowered blood glucose levels in patients with type 2 diabetes
Diabetes 64 , 819827 (2014)

Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass

Abstracts of the retrieved publications were manually reviewed to identify relevant articles that included any information related to switching between different GLP-1 receptor agonists

We further excluded individuals with a history of treatment with insulin before their initial prescription for a non-insulin glucose-lowering drug (since insulin therapy at baseline is considered for patients with advanced disease), women with a history of polycystic ovary syndrome or gestational diabetes, and individuals with type 1 diabetes